Related Experiment Video
Updated: Jul 9, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes
Xia Huang1, Haiyan Gu1, Ruxi Wu1
1Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Insights
Chest imaging findings in Mycoplasma pneumoniae pneumonia (MPP) correlate with clinical severity and outcomes. Consolidation/atelectasis indicates more severe disease, while mosaic patterns suggest milder cases in children.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Radiology
Background:
- Mycoplasma pneumoniae pneumonia (MPP) presents with diverse imaging findings.
- Limited research exists on the correlation between MPP imaging classifications and clinical outcomes.
Purpose of the Study:
- To prospectively examine the association between chest imaging classifications of MPP and its clinical features and outcomes in children.
Main Methods:
- 1,401 hospitalized children with MPP were analyzed.
- Imaging findings were classified using X-ray (bronchopneumonia, consolidation/atelectasis) and CT (bronchopneumonia, consolidation/atelectasis, bronchiolitis, mosaic pattern).
- Clinical data and outcomes were prospectively collected and analyzed.
Main Results:
- Bronchopneumonia was the most frequent finding (59.6%).
- Consolidation/atelectasis represented the most severe group, associated with significant clinical abnormalities, prolonged fever and hospitalization, increased costs, and higher risks of refractory MPP, necrotizing pneumonia, and bronchiolitis obliterans (BO).
- Mosaic patterns were linked to allergic/younger patients with wheezing, mild symptoms, and favorable outcomes.
Conclusions:
- Distinct imaging classifications of MPP correlate with specific clinical features and patient outcomes.
- An imaging-based classification system for MPP holds significant clinical value for predicting disease course and guiding management.
Background:
The imaging findings of Mycoplasma pneumoniae pneumonia (MPP) vary; however, few studies have focused on the relationship of imaging classification with clinical manifestations and outcomes.
Objective:
To prospectively investigate whether chest imaging classification in Mycoplasma pneumoniae pneumonia (MPP) is associated with its clinical features and outcomes.
Methods:
A total of 1,401 hospitalized children with MPP were enrolled from January 2019 to December 2021. Imaging findings were categorized as bronchopneumonia and consolidation/atelectasis according to X-ray, and bronchopneumonia, consolidation/atelectasis, bronchiolitis, and mosaic pattern according to computed tomography (CT). Clinical characteristics and outcomes of patients with different imaging classifications were prospectively analyzed based on electronic medical records.
Results:
Bronchopneumonia was the most common finding (59.6%), while consolidation/atelectasis was the most severe group. Clinical manifestations and laboratory indicators for the consolidation/atelectasis group included serious abnormalities. Further, outcomes of the patients were worse, including having longer total durations of fever and hospitalization, greater hospitalization expenses, and a higher likelihood of developing refractory MPP, necrotizing pneumonia, and bronchiolitis obliterans (BO) in this group. The incidence of bronchiolitis, a disease characterized by a high prevalence of fever, moist rales, and an atopic constitution, tended to increase after the coronavirus disease pandemic and predisposed patients to BO. A mosaic pattern occurred in allergic and young individuals, with wheezing as the main manifestation, with patients having relatively mild symptoms and good outcomes.
Conclusion:
Different imaging classifications have different clinical features and clinical outcomes; thus, formulating an imaging-based classification system is of great clinical value.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

